연구성과로 돌아가기

2023 연구성과별 연구자 정보 (1735 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
One-Unit Osteotomy to Correct Deviated Bony Dorsum Park, Song, I Park, SI 3 Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea 0000-0001-9499-7902 , Song I Park siamkhy@gmail.com;
One-Unit Osteotomy to Correct Deviated Bony Dorsum Hong, Sang Duk Hong, SD 4 Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea siamkhy@gmail.com;
One-Unit Osteotomy to Correct Deviated Bony Dorsum Jung, Yong Gi Jung, YG 5 Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea 0000-0001-7456-849X Jung, Yong gi siamkhy@gmail.com;
One-Unit Osteotomy to Correct Deviated Bony Dorsum Kim, Hyo Yeol Kim, HY 6 교신저자 Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea HLP-5150-2023 Kim, Hyo Yeol 0000-0002-2162-3202 Kim, Hyo Yeol siamkhy@gmail.com;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Song, Ga-Young Song, GY 1 Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Song, Ga-Young Song, GY 1 Chonnam Natl Univ, Med Sch, Hwasun, Jeollanamdo, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Lee, Je-Jung Lee, JJ 2 Chonnam Natl Univ, Dept Hematol Oncol, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea F-6974-2013 Lee, Jung-Hye shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Lee, Je-Jung Lee, JJ 2 Chonnam Natl Univ, Med Sch, Hwasun, Jeollanamdo, South Korea F-6974-2013 Lee, Jung-Hye shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Moon, Joon Ho Moon, JH 3 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Kim, Dajung Kim, D 4 Kosin Univ, Dept Internal Med, Gospel Hosp, Busan, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Kim, Min Kyoung Kim, MK 5 Yeungnam Univ, Dept Hematol & Oncol, Med Ctr, Daegu, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Kim, Hyo Jung Kim, HJ 6 Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Mun, Yeung-Chul Mun, YC 7 Ewha Womans Univ, Sch Med, Div Hematol Oncol, Seoul, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Lee, Won-Sik Lee, WS 8 Inje Univ, Busan Paik Hosp, Busan, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) Do, Young Rok Do, YR 9 Keimyung Univ, Keimyung Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea shglory@hanmail.net;HEMAKIM@yuhs.ac;
페이지 이동: